Movement disorders in 2019: from antibodies to lifestyle interventions

The Lancet Neurology

Fecha de publicación: January 2020


Autores: Claudia Trenkwalder, Brit Mollenhauer

Background: In 2019, many innovative findings were published that will be highly relevant for neuroprotection research in movement disorders. Substantial contributions from basic science have provided a better understanding of the propagation of α-synuclein, which has driven research into new therapies, such as the ongoing trials with antibodies against aggregated α-synuclein.

Seguir leyendo

Enviar comentario